Renal disorders involved in the pathophysiology of urinary excretion of α-1 microglobulin in patients with glomerulopathies

Clinical Nephrology

Volumn 72, Issue 6, 2009, Pages 473-481

  Romao E A ^a   Coimbra, T M ^a   Costa, R S ^a   Viera Neto, O M ^a   Reis, M A ^b   Rodrigues Junior, A L ^a   Ribeiro, R A ^a   Ravinal, R C ^a   Dantas, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

1; Glomerulopathy; Macrophage; MCP 1; Microglobulin; Tubulointerstitial damage

Indexed keywords

ALPHA 1 MICROGLOBULIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; AZATHIOPRINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CREATININE URINE LEVEL; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PROTEIN URINE LEVEL; PROTEINURIA; URINARY EXCRETION;

ADULT; ALPHA-GLOBULINS; BIOLOGICAL MARKERS; BIOPSY; CHEMOKINE CCL2; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES, PROXIMAL; MALE; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; PROTEINURIA;

EID: 71449108260     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.2379/CN106120     Document Type: Article

References (23)

1. Akerstrom B, Logdberg L, Berggard T, Osmark P, Lindqvist A. α(1)-Microglobulin: a yellow-brown lipocalin. Biochim Biophys Acta. 2000; 1482: 172-184.
2. Bakoush O, Grubb A, Rippe B, Tencer J. Urine excretion of protein HC in proteinuric glomerular diseases correlates to urine IgG but not to albuminuria. Kidney Int. 2001; 60: 1904-1909.
3. Bazzi C, Petrini C, Rizza V, Arrigo G, D'Amico G. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int. 2000; 58: 1732-1741.
4. Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, Pisano L, D'Amico G. Urinary excretion of IgG and α(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. Am J Kidney Dis. 2001; 38: 240-248.
5. Bazzi C, Petrini C, Rizza V, Napodano P, Paparella M, Arrigo G, Pisano L, D'Amico G. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study. Am J Kidney Dis. 2003; 41: 328-335.
6. Branten AJ, Wetzels JF. Influence of albumin infusion on the urinary excretion of β2-microglobulin in patients with proteinuria. Nephron. 1999; 81: 329-333.
7. D'Amico G. Tubulointerstitium as predictor of progression of glomerular diseases. Nephron. 1999; 83: 289-295.
8. D'Amico G, Bazzi C. Urinary protein and enzyme excretion as markers of tubular damage. Curr Opin Nephrol Hypertens. 2003; 12: 639-643.
9. Dantas M, Romao EA, Costa RS, dos Reis MA, Vieira Neto OM, Ribeiro RA, Ravinal RC, Rodrigues Junior AL, Coimbra TM. Urinary excretion of monocyte chemoattractant protein-1: a biomarker of active tubulointerstitial damage in patients with glomerulopathies. Kidney Blood Press Res. 2007; 30: 306-313.
10. du Buf-Vereijken PW, Wetzels JF. Treatment-related changes in urinary excretion of high and lowmolecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency. Nephrol Dial Transplant. 2006; 21: 389-396.
11. Eardley K, Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int. 2005; 68: 437-455.
12. Eardley KS, Zehnder D, Quinkler M, Lepenies J, Bates RL, Savage CO, Howie AJ, Adu D, Cockwell P. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int. 2006; 69: 1189-1197.
13. Eddy AA. Proteinuria and interstitial injury. Nephrol Dial Transplant. 2004; 19: 277-281.
14. Guder WG, Hofmann W. Clinical role of urinary low molecular weight proteins: their diagnostic and prognostic implications. Scand J Clin Lab Invest Suppl. 2008; 241: 95-98.
15. Kirsztajn GM, Nishida SK, Silva MS, Ajzen H, Moura LA, Pereira AB. Urinary retinol-binding protein as a prognostic marker in glomerulopathies. Nephron. 2002; 90: 424-431.
16. Murakami T, Kawakami H, Kobayashi K, Itoh Y. Glomerular α-1-microglobulin in IgA nephropathies. Am J Nephrol. 1989; 9: 438-439.
17. Nikolic-Paterson DJ, Atkins RC. The role of macrophages in glomerulonephritis. Nephrol Dial Transplant. 2001; 5: 3-7.
18. Pape L, Henne T, Offner G, Strehlau J, Ehrich JH, Mengel M, Grimm PC. Computer-assisted quantification of fibrosis in chronic allograft nephropaty by picosirius red-staining: a new tool for predicting long-term graft function. Transplantation. 2003; 76: 955-958.
19. Portman RJ, Kissane JM, Robson AM. Use of β 2 microglobulin to diagnose tubulo-interstitial renal lesions in children. Kidney Int. 1986; 30: 91-98.
20. Rovin BH, Doe N, Tan LC. Monocyte chemoattractant protein-1 levels in patients with glomerular disease Am J Kidney Dis. 1996; 27: 640-646.
21. Thielemans N, Lauwerys R, Bernard A. Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies. Nephron. 1994; 66: 453-458.
22. Valles P, Peralta M, Carrizo L, Martin L, Principi I, Gonzalez A, Manucha W. Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria. Pediatr Nephrol. 2000; 15: 252-258.
23. Yokota H, Hiramoto M, Okada H, Kanno Y, Yuri M, Morita S, Naitou M, Ichikawa A, Katoh M, Suzuki H. Absence of increased α1-microglobulin in IgA nephropathy proteinuria. Mol Cell Proteomics. 2007; 6: 738-744.